Beth Israel Deaconess Medical Center, Division of Vascular and Endovascular Surgery, Harvard Medical School, 110 Francis Street, Suite 5B, Boston, MA 02215, USA.
Beth Israel Deaconess Medical Center, Division of Vascular and Endovascular Surgery, Harvard Medical School, 110 Francis Street, Suite 5B, Boston, MA 02215, USA.
Adv Surg. 2022 Sep;56(1):111-127. doi: 10.1016/j.yasu.2022.02.004. Epub 2022 Jul 20.
Transcarotid artery revascularization (TCAR) is a novel carotid stenting method that avoids the manipulation of the aortic arch and uses a flow-reversal neuroprotection system that effectively reduces the risk of embolic events during carotid intervention. Studies have shown a lower risk of stroke or death compared with the transfemoral carotid stenting approach, and an equivalent risk of stroke or death compared with traditional carotid endarterectomy. TCAR has added benefits of lower risk of myocardial infarction, cranial nerve injuries, and shorter operative times compared with endarterectomy. TCAR has become widely adopted by vascular surgeons in the United States for the treatment of patients with high-risk medical comorbidities and those with challenging surgical anatomy.
经颈动脉血管重建术(TCAR)是一种新型颈动脉支架置入方法,它避免了主动脉弓的操作,并采用了血流反转神经保护系统,可有效降低颈动脉介入治疗过程中栓塞事件的风险。研究表明,与经股动脉颈动脉支架置入术相比,TCAR 术式的中风或死亡风险较低,与传统颈动脉内膜切除术相比,中风或死亡风险相当。与颈动脉内膜切除术相比,TCAR 具有较低的心肌梗死、颅神经损伤和较短的手术时间风险。在美国,血管外科医生广泛采用 TACR 治疗患有高危合并症的患者和具有挑战性手术解剖结构的患者。